| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.25 | 3e-05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.76 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |